Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiac and Cerebral Haemodynamic Changes in Obstructive Sleep Apnea Assessed With Real Time and 4D Flow MRI During Apnea, Rest and CPAP.

NCT07913269 is registered in ClinicalTrials.gov with Copenhagen University Hospital, Rigshospitalet as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07913269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiac and Cerebral Haemodynamic Changes in Obstructive Sleep Apnea Assessed With Real Time and 4D Flow MRI During Apnea, Rest and CPAP.
Lead sponsor
Copenhagen University Hospital, Rigshospitalet
Phase
Observational
Overall status
Not yet recruiting
Start date
November 15, 2026
Completion date
November 15, 2028
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea (osa)

Arms

As registered; 2 arms.

  • Severe obstructive sleep apnea

    Adults aged 18 to 65 years with AHI at least 30 events per hour. Participants undergo MRI at rest and during the Mueller and Valsalva maneuvers, real time flow measurements during spontaneous obstructive apneas, and 4D flow MRI during CPAP.

  • Controls

    Adults aged 18 to 65 years referred for assessment of suspected OSA, with AHI below 5 events per hour. Participants undergo MRI at rest and during the Mueller and Valsalva maneuvers.

Primary endpoints

Registered primary outcome measures; 2 primary.

  • Change in volumetric blood flow rate during spontaneous obstructive apneas At baseline and after 6 months CPAP treatment

    Percentage change in volumetric blood flow rate Q(t), measured with real time 2D phase contrast MRI in the ascending aorta, superior vena cava, bilateral internal carotid arteries, bilateral vertebral arteries, bilateral internal jugular veins and superior sagittal sinus. Each vessel is assessed separately by comparing the baseline immediately before an event with phases of obstructive effort, desaturation and apnea termination. The analysis is restricted to participants with OSA. At least three usable obstructive apneas per location or measurement plane are targeted.

  • Change in peak blood velocity during spontaneous obstructive apneas At baseline and after 6 months CPAP treatment

    Percentage change in peak blood velocity, measured with real time 2D phase contrast MRI in the ascending aorta, superior vena cava, bilateral internal carotid arteries, bilateral vertebral arteries, bilateral internal jugular veins and superior sagittal sinus. Each vessel is assessed separately by comparing the baseline immediately before an event with phases of obstructive effort, desaturation and apnea termination. Underlying velocity measurements are expressed in cm/s. The analysis is restricted to participants with OSA.

Lead sponsor's other trials

Copenhagen University Hospital, Rigshospitalet, most recent start first.

Similar trials

Same condition (Sleep Apnea, Obstructive) and phase, most recent start first.